Cerebral atrophy

• Stroke, loss of brain function due to a sudden interruption of blood supply in the brain
• Traumatic brain injury
• Corticosteroid use (There appears to be correlations between degree of dosing with corticosteroids and cerebral atrophy)[3]
• Environmental pollutants [4]

Pick's Disease showing brain atrophy,

• Alzheimer's disease (High resolution MRI scans have shown the progression of cerebral atrophy in Alzheimer's disease)[5]
• Cerebral palsy, in which lesions (damaged areas) may impair motor coordination
• Senile dementia, fronto-temporal dementia, and vascular dementia
• Pick’s disease, causes progressive destruction of nerve cells in the brain
• Huntington's disease, and other genetic disorders that cause build-up of toxic levels of proteins in neurons
• Leukodystrophies, such as Krabbe disease, which destroy the myelin sheath that protects axons
• Multiple sclerosis, which causes inflammation, myelin damage, and lesions in cerebral tissue
• Epilepsy, in which lesions cause abnormal electrochemical discharges that result in seizures
• Anorexia nervosa, bulimia nervosa, and other eating disorders
• Malnutrition, caused by lack or excess of nutrition from foods
• Type II diabetes, where the body does not use insulin properly resulting in high blood sugar
• Bipolar disorder,[6] significant loss of brain tissue during manic episodes; however it's not verified whether the episodes cause brain tissue loss or vice versa
• Schizophrenia[7]
• Mitochondrial encephalomyopathies, such as Kearns-Sayre syndrome, which interfere with the basic functions of neurons
• Posterior cortical atrophy: In the most posterior area of the brain lies the visual cortex, the area of the brain where visual information is received and processed. When cortical atrophy occurs in this brain area due to neurodegeneration, the first symptom is impairment in vision. A common vision impairment seen in patients with posterior cortical atrophy is simultanagnosia, where a person is unable to see multiple locations at once or to quickly shift attention between these locations. When looking at images of a brain suffering from posterior cortical atrophy, one can see a loss in volume of the dorsal and ventral visual pathways, where visual stimuli is brought to the visual cortex and integrated information is sent back out to other areas of the brain. Because this disorder results in visual impairments, there is often a missed or delayed diagnosis, as the assumption is that there is a problem is in the eyes when the reality is that the problem is all the way in the back of the brain.[8]
• Prion diseases, a group of invariably fatal encephalopathies that cause the progressive death of neurons.

Where an infectious agent or the inflammatory reaction to it destroys neurons and their axons, these include...

• Encephalitis, acute inflammation in the brain
• Neurosyphilis, an infection in the brain or spinal chord
• AIDS, disease of the immune system

• Alcohol [9]
• Neuroleptic

Cerebrospinal fluid (CSF) is a fluid that is found exclusively in the brain and spinal cord that circulates between sections of the brain offering an extra layer of protection. Studies have shown that biomarkers in the CSF and plasma can be tracked for their presence in different parts of the brain—and their presence can tell us about cerebral atrophy. One study took advantage of biomarkers, namely one called neurofilament light chain (NFL), in patients with Alzheimer’s Disease. Neurofilament light chain is a protein that is important in the growth and branching of neurons—cells found in the brain. In Alzheimer’s Disease, neurons will stop working or die in a process called neurodegeneration. By tracking NFL, researchers can see this neurodegeneration, which this study showed was associated with brain atrophy and later cognitive decline in Alzheimer's patients. Other biomarkers like Ng – a protein important in long-term potentiation and memory – have been tracked for their associations with brain atrophy as well, but NFL had the greatest association.[10]

Brain CT with different grading systems of cerebral atrophy (seen as decreased size of gyri and secondary increased size of sulci):[11]
- Medial temporal lobe atrophy (MTA)
- Posterior atrophy (PA)
- Frontal cortical atrophy (fGCA)

CT and MRI are most commonly used to observe the brain for cerebral atrophy. A CT scan takes cross sectional images of the brain using X-rays, while an MRI uses a magnetic field. With both measures, multiple images can be compared to see if there is a loss in brain volume over time.[12]

Cerebral atrophy can be hard to distinguish from hydrocephalus because both cerebral atrophy and hydrocephalus involve an increase in cerebrospinal fluid (CSF) volume. In cerebral atrophy, this increase in CSF volume comes as a result of the decrease in cortical volume. In hydrocephalus, the increase in volume happens due to the CSF itself.[12]

Typical imaging findings in normal pressure hydrocephalus versus brain atrophy.[13]

	Normal pressure hydrocephalus	Brain atrophy
Preferable projection	Coronal plane at the level of the posterior commissure of the brain.
Modality in this example	CT	MRI
CSF spaces over the convexity near the vertex (red ellipse )	Narrowed convexity ("tight convexity") as well as medial cisterns	Widened vertex (red arrow) and medial cisterns (green arrow)
Callosal angle (blue V)	Acute angle	Obtuse angle
Most likely cause of leucoaraiosis (periventricular signal alterations, blue arrows )	Transependymal cerebrospinal fluid diapedesis	Vascular encephalopathy, in this case suggested by unilateral occurrence

While most cerebral atrophy is said to be irreversible there are some recent studies that show this is not always the case. A child who was treated with ACTH originally showed atrophy, but four months after treatment the brain was seemingly normal again.[15]

Chronic alcoholism is known to be associated with cerebral atrophy in addition to motor dysfunction and impairment in higher brain function. Because some of the behavioral deficits have shown improvement after abstinence from alcohol, a study looked to see if cerebral atrophy could be reversed too. Researchers took CT scans of the 8 study participants in order to measure cortical volume over time. Although decrease in atrophy does not equate clinical improvement, the CT scans of 50% of participants showed partial improvement, giving hope that cerebral atrophy could be a reversible process.[9]